epidermal growth factor receptor

You have access
First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea
MI-HYUN KIM, CHANG MIN CHOI, SUNG YONG LEE, CHEOL KYU PARK, YOON SOO CHANG, KYE YOUNG LEE, SEUNG JOON KIM, SEI HOON YANG, JEONG SEON RYU, JEONG EUN LEE, SHIN YUP LEE, CHAN KWON PARK, SANG HOON LEE, SEUNG HUN JANG, SEONG HOON YOON and TAE WON JANG

Anticancer Research March 2022, 42 (3) 1615-1622; DOI: https://doi.org/10.21873/anticanres.15636
You have access
A Novel Molecular Target in EGFR-mutant Lung Cancer Treated With the Combination of Osimertinib and Pemetrexed
NATSUKI TAKANO, MASAHIRO SEIKE, TEPPEI SUGANO, KUNIKO MATSUDA, KAKERU HISAKANE, AKIKO YOSHIKAWA, SHINJI NAKAMICHI, RINTARO NORO and AKIHIKO GEMMA

Anticancer Research February 2022, 42 (2) 709-722; DOI: https://doi.org/10.21873/anticanres.15529
You have access
Comparison Between Second- and Third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as First-line Treatment in Patients With Non-small-cell Lung Cancer: A Retrospective Analysis
SHO MITSUYA, KENJIRO TSURUOKA, KIYOE KANAOKA, TOMOYA FUNAMOTO, HIROYUKI TSUJI, NINSO MATSUNAGA, TAKAHIKO NAKAMURA, YOSUKE TAMURA, MASAFUMI IMANISHI, SOICHIRO IKEDA, YASUHITO FUJISAKA, ISAO GOTO and AKIHISA IMAGAWA

Anticancer Research October 2021, 41 (10) 5137-5145; DOI: https://doi.org/10.21873/anticanres.15331
You have access
Epidermal Growth Factor Based Targeted Toxin for the Treatment of Bladder Cancer
ANIE PRISCILLA MASILAMANI, ALEXANDRA FISCHER, SUSANNE SCHULTZE-SEEMANN, IRINA KUCKUCK, ISIS WOLF, FRANZ FRIEDRICH DRESSLER, CHRISTIAN GRATZKE and PHILIPP WOLF

Anticancer Research August 2021, 41 (8) 3741-3746; DOI: https://doi.org/10.21873/anticanres.15165
You have access
Lewis y Expressed in Oral Squamous Cell Carcinoma Attenuates Malignant Properties via Down-regulation of EGF Signaling
HIROSHI HOTTA, KAZUNORI HAMAMURA, HIDENOBU SHIBUYA, YUHSUKE OHMI, KEIKO FURUKAWA and KOICHI FURUKAWA

Anticancer Research April 2021, 41 (4) 1821-1830; DOI: https://doi.org/10.21873/anticanres.14948
You have access
Epidermal Growth Factor Receptor and its Oncogenic EGFRvIII Variant in Benign and Malignant Brain Tumors
MICHAL KIELBUS, RADOSLAW ROLA, BOZENA JAROSZ, WITOLD JELENIEWICZ, MAREK CYBULSKI, AGNIESZKA STENZEL-BEMBENEK, ARKADIUSZ PODKOWINSKI, JOLANTA SMOK-KALWAT, KRZYSZTOF POLBERG, TOMASZ TROJANOWSKI, DAWID STEFANIUK and ANDRZEJ STEPULAK

Anticancer Research February 2021, 41 (2) 983-991; DOI: https://doi.org/10.21873/anticanres.14852
You have access
Treatment of Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in Clinical Practice
YUTAKA YAMADA, TOMOHIRO TAMURA, YUSUKE YAMAMOTO, HIDEO ICHIMURA, KENJI HAYASHIHARA, TAKEFUMI SAITO, HIDEYASU YAMADA, TAKEO ENDO, RYOTA NAKAMURA, YOSHIHISA INAGE, HIROAKI SATOH, KESATO IGUCHI, KAZUTO SAITO, MASAHARU INAGAKI, NORIHIRO KIKUCHI, KOICHI KURISHIMA, HIROICHI ISHIKAWA, MITSUAKI SAKAI, KOICHI KAMIYAMA, TOSHIHIRO SHIOZAWA, NOBUYUKI HIZAWA, IKUO SEKINE, YUKIO SATO, YASUNORI FUNAYAMA, KUNIHIKO MIYAZAKI, TAKAHIDE KODAMA, SHIGEN HAYASHI, AKIHIRO NOMURA, HIROYUKI NAKAMURA, KINYA FURUKAWA, TAKAAKI YAMASHITA, HATSUMI OKUBO, HISASHI SUZUKI, MORIYUKI KIYOSHIMA and TAKAYUKI KABURAGI

Anticancer Research October 2020, 40 (10) 5757-5764; DOI: https://doi.org/10.21873/anticanres.14592
You have access
Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer
ANA LAURA ORTEGA-GRANADOS, ÁNGEL ARTAL-CORTES, DAVID AGUIAR-BUJANDA, JUANA ORAMAS, JOSÉ LUIS FÍRVIDA, JAVIER DE CASTRO, JUANA CAMPILLO FUENTES, ROCÍO GORDO, RAQUEL GALÁN, JOSÉ TRIGO and on behalf of the ASPET Study Investigators

Anticancer Research March 2019, 39 (3) 1317-1328; DOI: https://doi.org/10.21873/anticanres.13244
You have access
Radiolabeling, Characteristics and NanoSPECT/CT Imaging of 188Re-cetuximab in NCI-H292 Human Lung Cancer Xenografts
WAN-I KUO, KAI-HUNG CHENG, YA-JEN CHANG, TSUNG-TSE WU, WEI-CHUAN HSU, LIANG-CHENG CHEN and CHIH-HSIEN CHANG

Anticancer Research January 2019, 39 (1) 183-190; DOI: https://doi.org/10.21873/anticanres.13096
You have access
A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer
MATTHEW R. KEARNEY, EMERSON Y. CHEN, GINA M. VACCARO, JOHN STROTHER, ANDREA BURT, KENDRA TODD, JEFF DONOVAN, KERSTIN M. KAMPA-SCHITTENHELM and CHARLES D. LOPEZ

Anticancer Research January 2019, 39 (1) 245-252; DOI: https://doi.org/10.21873/anticanres.13104

Main menu

User menu

Search

epidermal growth factor receptor

Pages